Andrea Catherine Enzinger, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Terminal Care | 18 | 2023 | 1774 | 1.900 |
Why?
|
Neoplasms | 35 | 2024 | 22340 | 1.650 |
Why?
|
Spirituality | 15 | 2019 | 430 | 1.360 |
Why?
|
Patient Education as Topic | 4 | 2023 | 2334 | 1.100 |
Why?
|
Multimedia | 2 | 2023 | 76 | 0.980 |
Why?
|
Analgesics, Opioid | 7 | 2024 | 3835 | 0.900 |
Why?
|
Palliative Care | 12 | 2024 | 3645 | 0.900 |
Why?
|
Video Games | 1 | 2024 | 203 | 0.780 |
Why?
|
Rosa | 1 | 2021 | 8 | 0.780 |
Why?
|
Life Expectancy | 2 | 2020 | 1247 | 0.730 |
Why?
|
Bereavement | 1 | 2022 | 308 | 0.600 |
Why?
|
Death | 4 | 2023 | 686 | 0.550 |
Why?
|
Peritoneal Neoplasms | 4 | 2024 | 703 | 0.550 |
Why?
|
Religion | 6 | 2019 | 376 | 0.550 |
Why?
|
Physician-Patient Relations | 6 | 2018 | 3278 | 0.490 |
Why?
|
Religion and Medicine | 5 | 2017 | 162 | 0.450 |
Why?
|
Caregivers | 8 | 2024 | 2307 | 0.410 |
Why?
|
Truth Disclosure | 1 | 2015 | 433 | 0.370 |
Why?
|
Patient Participation | 2 | 2018 | 1455 | 0.370 |
Why?
|
Telemedicine | 4 | 2024 | 3105 | 0.360 |
Why?
|
Informed Consent | 1 | 2017 | 1010 | 0.350 |
Why?
|
Comprehension | 1 | 2015 | 638 | 0.330 |
Why?
|
Advance Care Planning | 6 | 2024 | 702 | 0.330 |
Why?
|
Nurses | 4 | 2014 | 2505 | 0.310 |
Why?
|
Communication | 3 | 2022 | 3916 | 0.310 |
Why?
|
Quality of Life | 7 | 2024 | 13462 | 0.300 |
Why?
|
Adaptation, Psychological | 6 | 2019 | 2660 | 0.300 |
Why?
|
Clergy | 3 | 2017 | 79 | 0.290 |
Why?
|
Colorectal Neoplasms | 3 | 2024 | 6942 | 0.280 |
Why?
|
Neuroendocrine Tumors | 2 | 2025 | 654 | 0.280 |
Why?
|
Hospice Care | 5 | 2023 | 678 | 0.270 |
Why?
|
Advance Directives | 2 | 2015 | 251 | 0.270 |
Why?
|
Attitude of Health Personnel | 7 | 2020 | 3925 | 0.240 |
Why?
|
Health Services Accessibility | 2 | 2021 | 5508 | 0.230 |
Why?
|
Qualitative Research | 3 | 2024 | 3139 | 0.220 |
Why?
|
Morals | 2 | 2017 | 288 | 0.220 |
Why?
|
Humans | 56 | 2025 | 765968 | 0.220 |
Why?
|
Genital Neoplasms, Female | 3 | 2024 | 533 | 0.210 |
Why?
|
Prognosis | 6 | 2023 | 29922 | 0.210 |
Why?
|
Attitude to Death | 3 | 2011 | 399 | 0.210 |
Why?
|
Quality Improvement | 2 | 2020 | 3853 | 0.200 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5444 | 0.200 |
Why?
|
Middle Aged | 32 | 2025 | 223009 | 0.200 |
Why?
|
Aged | 24 | 2025 | 171117 | 0.190 |
Why?
|
Drug Prescriptions | 2 | 2021 | 1662 | 0.190 |
Why?
|
Stress, Psychological | 2 | 2020 | 4533 | 0.180 |
Why?
|
Faith Healing | 1 | 2011 | 25 | 0.180 |
Why?
|
Physicians | 4 | 2014 | 4588 | 0.180 |
Why?
|
Nurse Practitioners | 1 | 2024 | 272 | 0.180 |
Why?
|
Terminally Ill | 1 | 2012 | 241 | 0.170 |
Why?
|
Female | 38 | 2025 | 396112 | 0.170 |
Why?
|
Decision Making | 4 | 2024 | 3965 | 0.170 |
Why?
|
Drug Therapy | 1 | 2023 | 504 | 0.170 |
Why?
|
Male | 34 | 2025 | 363698 | 0.160 |
Why?
|
Life Support Care | 2 | 2017 | 226 | 0.160 |
Why?
|
Spiritual Therapies | 1 | 2009 | 60 | 0.160 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2021 | 347 | 0.150 |
Why?
|
Biomedical Technology | 1 | 2021 | 210 | 0.150 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2024 | 961 | 0.150 |
Why?
|
Carcinoid Tumor | 1 | 2019 | 225 | 0.150 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2023 | 1333 | 0.140 |
Why?
|
Appendiceal Neoplasms | 1 | 2019 | 155 | 0.140 |
Why?
|
Fatigue | 2 | 2022 | 1549 | 0.140 |
Why?
|
Adult | 23 | 2025 | 223044 | 0.140 |
Why?
|
Patient Access to Records | 1 | 2018 | 120 | 0.140 |
Why?
|
Pamphlets | 1 | 2017 | 71 | 0.140 |
Why?
|
Patient Preference | 2 | 2015 | 952 | 0.140 |
Why?
|
Pilot Projects | 3 | 2024 | 8733 | 0.130 |
Why?
|
Interviews as Topic | 4 | 2016 | 2739 | 0.130 |
Why?
|
Attitude to Health | 2 | 2019 | 2020 | 0.130 |
Why?
|
Appendectomy | 1 | 2019 | 444 | 0.130 |
Why?
|
Feasibility Studies | 2 | 2024 | 5302 | 0.130 |
Why?
|
Faculty | 2 | 2016 | 384 | 0.120 |
Why?
|
Drug Utilization | 1 | 2021 | 1187 | 0.120 |
Why?
|
Medical Oncology | 3 | 2023 | 2339 | 0.120 |
Why?
|
Culture | 1 | 2018 | 622 | 0.110 |
Why?
|
Critical Care | 3 | 2017 | 2712 | 0.110 |
Why?
|
Education, Medical | 2 | 2016 | 1746 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1394 | 0.110 |
Why?
|
Medicare | 2 | 2023 | 6823 | 0.110 |
Why?
|
Religion and Psychology | 3 | 2019 | 179 | 0.110 |
Why?
|
Electronic Health Records | 2 | 2022 | 4873 | 0.100 |
Why?
|
Disclosure | 1 | 2018 | 756 | 0.100 |
Why?
|
Schools, Medical | 2 | 2016 | 876 | 0.100 |
Why?
|
Video Recording | 1 | 2017 | 969 | 0.090 |
Why?
|
Radiation Oncology | 1 | 2017 | 569 | 0.090 |
Why?
|
Aged, 80 and over | 5 | 2025 | 59489 | 0.090 |
Why?
|
United States | 8 | 2023 | 72903 | 0.090 |
Why?
|
Guideline Adherence | 1 | 2020 | 2243 | 0.090 |
Why?
|
Psychometrics | 1 | 2019 | 3062 | 0.080 |
Why?
|
Focus Groups | 3 | 2024 | 1459 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2025 | 11868 | 0.080 |
Why?
|
Nausea | 2 | 2024 | 680 | 0.080 |
Why?
|
Early Detection of Cancer | 1 | 2023 | 3236 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2011 | 3475 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 2178 | 0.070 |
Why?
|
Health Care Costs | 1 | 2011 | 3242 | 0.070 |
Why?
|
Resuscitation Orders | 2 | 2011 | 275 | 0.070 |
Why?
|
Nurse-Patient Relations | 2 | 2014 | 102 | 0.070 |
Why?
|
Prevalence | 2 | 2021 | 15842 | 0.070 |
Why?
|
Veterans | 1 | 2020 | 2664 | 0.070 |
Why?
|
Emotions | 2 | 2015 | 2763 | 0.060 |
Why?
|
Students, Medical | 2 | 2016 | 1959 | 0.060 |
Why?
|
Prospective Studies | 6 | 2023 | 54802 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 6209 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5446 | 0.060 |
Why?
|
Boston | 3 | 2012 | 9338 | 0.060 |
Why?
|
Health Promotion | 1 | 2016 | 2208 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5719 | 0.060 |
Why?
|
Regression Analysis | 1 | 2013 | 6322 | 0.060 |
Why?
|
Odds Ratio | 1 | 2015 | 9649 | 0.050 |
Why?
|
Curriculum | 1 | 2016 | 3782 | 0.050 |
Why?
|
Somatostatin | 1 | 2025 | 459 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2024 | 15880 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8626 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7875 | 0.050 |
Why?
|
Pastoral Care | 1 | 2012 | 72 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9373 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7425 | 0.040 |
Why?
|
Pain | 3 | 2024 | 5077 | 0.040 |
Why?
|
Nurse's Role | 1 | 2022 | 187 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2023 | 384 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 26318 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 634 | 0.040 |
Why?
|
Self Efficacy | 1 | 2024 | 642 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 40065 | 0.040 |
Why?
|
Constipation | 1 | 2024 | 568 | 0.040 |
Why?
|
Self Report | 2 | 2024 | 3770 | 0.040 |
Why?
|
Social Perception | 1 | 2012 | 436 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 24282 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 618 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8041 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2011 | 7838 | 0.040 |
Why?
|
User-Computer Interface | 1 | 2024 | 1405 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 816 | 0.040 |
Why?
|
Quality of Health Care | 2 | 2012 | 4300 | 0.040 |
Why?
|
Logistic Models | 2 | 2012 | 13266 | 0.030 |
Why?
|
Age of Onset | 1 | 2024 | 3344 | 0.030 |
Why?
|
Christianity | 1 | 2017 | 52 | 0.030 |
Why?
|
Internship and Residency | 1 | 2017 | 5946 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2009 | 621 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2012 | 6203 | 0.030 |
Why?
|
Spiritualism | 1 | 2014 | 18 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2011 | 2424 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2018 | 616 | 0.030 |
Why?
|
Hospices | 1 | 2017 | 245 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2054 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5370 | 0.030 |
Why?
|
Linear Models | 1 | 2012 | 5876 | 0.030 |
Why?
|
Trust | 1 | 2017 | 533 | 0.020 |
Why?
|
Sampling Studies | 1 | 2013 | 607 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3513 | 0.020 |
Why?
|
Pain Measurement | 1 | 2021 | 3561 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21056 | 0.020 |
Why?
|
Paclitaxel | 1 | 2018 | 1728 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3230 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20124 | 0.020 |
Why?
|
Perception | 1 | 2014 | 1205 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8529 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2020 | 3615 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5929 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5696 | 0.020 |
Why?
|
Concept Formation | 1 | 1987 | 159 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12795 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11206 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39193 | 0.020 |
Why?
|
Critical Illness | 1 | 2016 | 2744 | 0.010 |
Why?
|
Algorithms | 1 | 2024 | 14071 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 41649 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2009 | 14751 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 4058 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10808 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 30198 | 0.010 |
Why?
|
Young Adult | 1 | 2010 | 59889 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 81514 | 0.010 |
Why?
|
Free Association | 1 | 1987 | 6 | 0.000 |
Why?
|
Semantics | 1 | 1987 | 610 | 0.000 |
Why?
|